Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting, 76279-76280 [2015-30861]

Download as PDF Federal Register / Vol. 80, No. 235 / Tuesday, December 8, 2015 / Notices The applicant is requesting an amendment to the permit to increase the number of animals that samples could be received, imported, and exported from 25 to 100 individuals annually. In addition, the applicant is requesting authorization to receive, import, and export baleen samples from blue and fin whales. No takes of live animals are or would be authorized. The permit expires on July 17, 2017. In compliance with the National Environmental Policy Act of 1969 (42 U.S.C. 4321 et seq.), an initial determination has been made that the activity proposed is categorically excluded from the requirement to prepare an environmental assessment or environmental impact statement. Concurrent with the publication of this notice in the Federal Register, NMFS is forwarding copies of this application to the Marine Mammal Commission and its Committee of Scientific Advisors. Dated: December 2, 2015. Julia Harrison, Chief, Permits and Conservation Division, Office of Protected Resources, National Marine Fisheries Service. [FR Doc. 2015–30843 Filed 12–7–15; 8:45 am] BILLING CODE 3510–22–P CORPORATION FOR NATIONAL AND COMMUNITY SERVICE Lhorne on DSK9F6TC42PROD with NOTICES Sunshine Act Meeting Notice The Board of Directors of the Corporation for National and Community Service gives notice of the following meeting: DATE AND TIME: Friday, December 18, 2015, 11:30 a.m.–12:30 p.m. (ET). PLACE: Corporation for National and Community Service, 1201 New York Avenue NW., Suite 8312, Washington, DC 20525 (Please go to 10th floor reception area for escort). CALL-IN INFORMATION: This meeting is available to the public through the following toll-free call-in number: 800– 988–9648 conference call access code number 5755950. Any interested member of the public may call this number and listen to the meeting. Callers can expect to incur charges for calls they initiate over wireless lines, and CNCS will not refund any incurred charges. Callers will incur no charge for calls they initiate over land-line connections to the toll-free telephone number. Replays are generally available one hour after a call ends. The toll-free phone number for the replay is 800– 843–4802, access code number 22589. TTY: 800–833–3722. The end replay VerDate Sep<11>2014 14:17 Dec 07, 2015 Jkt 238001 date is January 18, 2016, 11:29 p.m. (CT). STATUS: Open. MATTERS TO BE CONSIDERED: I. Chair’s Opening Comments a. Call to Order, Welcome, and Preview of Today’s Meeting Agenda b. Introduction and Acknowledgements c. Summary Status of Board Interaction II. Consideration of Previous Meeting’s Minutes III. CEO Report IV. Guest Speaker: Highlighting MLK Day of Service V. Public Comments VI. Final Comments and Adjournment Members of the public who would like to comment on the business of the Board may do so in writing or in person. Individuals may submit written comments to jmauk@cns.gov subject line: DECEMBER 2015 CNCS BOARD MEETING by 4:00 p.m. (ET) on December 16, 2015. Individuals attending the meeting in person who would like to comment will be asked to sign-in upon arrival. Comments are requested to be limited to 2 minutes. REASONABLE ACCOMMODATIONS: The Corporation for National and Community Service provides reasonable accommodations to individuals with disabilities where appropriate. Anyone who needs an interpreter or other accommodation should notify Ida Green at igreen@cns.gov or 202–606–6861 by 5 p.m. (ET) on December 15, 2015. CONTACT PERSON FOR MORE INFORMATION: Jenny Mauk, Special Assistant to the CEO, Corporation for National and Community Service, 1201 New York Avenue NW., Washington, DC 20525. Phone: 202–606–6615. Fax: 202–606– 3460. TTY: 800–833–3722. Email: jmauk@cns.gov. Dated: December 4, 2015. Wilsie Y. Minor, Deputy General Counsel. [FR Doc. 2015–31004 Filed 12–4–15; 4:15 pm] BILLING CODE 6050–28–P DEPARTMENT OF DEFENSE Office of the Secretary Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting Assistant Secretary of Defense (Health Affairs), DoD. ACTION: Notice of meeting. AGENCY: The Department of Defense is publishing this notice to announce a SUMMARY: PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 76279 Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel). DATES: Thursday, January 7, 2016, from 9:00 a.m. to 1:00 p.m. ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: CAPT Edward Norton, DFO, Uniform Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Telephone: (703) 681–2890. Fax: (703) 681–1940. Email Address: dha.ncr.health-it.mbx.baprequests@ mail.mil. This meeting is being held under the provisions of the Federal Advisory Committee Act of 1972 (Title 5, United States Code (U.S.C.), Appendix, as amended) and the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended). Purpose of Meeting: The Panel will review and comment on recommendations made to the Director of Defense Health Agency, by the Pharmacy and Therapeutics Committee, regarding the Uniform Formulary. SUPPLEMENTARY INFORMATION: Meeting Agenda 1. Sign-In 2. Welcome and Opening Remarks 3. Public Citizen Comments 4. Scheduled Therapeutic Class Reviews (Comments will follow each agenda item) a. Attention Deficit Hyperactivity Disorder (ADHD)—Stimulants b. Antirheumatic Drugs— Methotrexate Injectable c. Gastrointestinal -2 Agents— Miscellaneous d. Acne—Isotretinoins 5. Designated Newly Approved Drugs in Already-Reviewed Classes 6. Designated Newly FDA Approved Drugs 7. Pertinent Utilization Management Issues 8. Panel Discussions and Vote Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 Code of Federal Regulations (CFR) 102–3.140 through 102–3.165, and the availability of space, this meeting is open to the public. Seating is limited and will be provided only to the first 220 people signing-in. All persons must sign-in legibly. Administrative Work Meeting: Prior to the public meeting, the Panel will conduct an Administrative Work Meeting from 7:45 a.m. to 9:00 a.m. to discuss administrative matters of the E:\FR\FM\08DEN1.SGM 08DEN1 Lhorne on DSK9F6TC42PROD with NOTICES 76280 Federal Register / Vol. 80, No. 235 / Tuesday, December 8, 2015 / Notices Panel. The Administrative Work Meeting will be held at the Naval Heritage Center, 701 Pennsylvania Avenue NW., Washington, DC 20004. Pursuant to 41 CFR 102–3.160, the Administrative Work Meeting will be closed to the public. Written Statements: Pursuant to 41 CFR 102–3.140, the public or interested organizations may submit written statements to the membership of the Panel at any time or in response to the stated agenda of a planned meeting. Written statements should be submitted to the Panel’s Designated Federal Officer (DFO). The DFO’s contact information can be obtained from the General Services Administration’s Federal Advisory Committee Act Database at https://facadatabase.gov/. Written statements that do not pertain to the scheduled meeting of the Panel may be submitted at any time. However, if individual comments pertain to a specific topic being discussed at a planned meeting, then these statements must be submitted no later than 5 business days prior to the meeting in question. The DFO will review all submitted written statements and provide copies to all the committee members. Public Comments: In addition to written statements, the Panel will set aside 1 hour for individuals or interested groups to address the Panel. To ensure consideration of their comments, individuals and interested groups should submit written statements as outlined in this notice; but if they still want to address the Panel, then they will be afforded the opportunity to register to address the Panel. The Panel’s DFO will have a ‘‘Sign-Up Roster’’ available at the Panel meeting for registration on a first-come, first-serve basis. Those wishing to address the Panel will be given no more than 5 minutes to present their comments, and at the end of the 1 hour time period, no further public comments will be accepted. Anyone who signs-up to address the Panel, but is unable to do so due to the time limitation, may submit their comments in writing; however, they must understand that their written comments may not be reviewed prior to the Panel’s deliberation. To ensure timeliness of comments for the official record, the Panel encourages that individuals and interested groups consider submitting written statements instead of addressing the Panel. VerDate Sep<11>2014 14:17 Dec 07, 2015 Jkt 238001 Dated: December 3, 2015. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. Comments Due: 5 p.m. ET 12/23/15. Docket Numbers: ER16–453–000. Applicants: PJM Interconnection, L.L.C., Northeast Transmission Development, LLC. [FR Doc. 2015–30861 Filed 12–7–15; 8:45 am] Description: § 205(d) Rate Filing: NTD BILLING CODE 5001–06–P submits Attachment H—ATRR, Formula Rate, and Formula Protocols to be effective 2/1/2016. DEPARTMENT OF ENERGY Filed Date: 12/2/15. Accession Number: 20151202–5207. Federal Energy Regulatory Comments Due: 5 p.m. ET 12/23/15. Commission The filings are accessible in the Commission’s eLibrary system by Combined Notice of Filings #2 clicking on the links or querying the Take notice that the Commission docket number. received the following electric rate Any person desiring to intervene or filings: protest in any of the above proceedings must file in accordance with Rules 211 Docket Numbers: ER10–2331–048; ER14–630–024; ER10–2319–039; ER10– and 214 of the Commission’s 2317–039; ER13–1351–021; ER10–2330– Regulations (18 CFR 385.211 and 385.214) on or before 5:00 p.m. Eastern 046. time on the specified comment date. Applicants: J.P. Morgan Ventures Protests may be considered, but Energy Corporation, AlphaGen Power intervention is necessary to become a LLC, BE Alabama LLC, BE CA LLC, Florida Power Development LLC, Utility party to the proceeding. eFiling is encouraged. More detailed Contract Funding, L.L.C. information relating to filing Description: Notice of Non-Material requirements, interventions, protests, Change in Status of JPMorgan Sellers. service, and qualifying facilities filings Filed Date: 12/2/15. can be found at: https://www.ferc.gov/ Accession Number: 20151202–5154. docs-filing/efiling/filing-req.pdf. For Comments Due: 5 p.m. ET 12/23/15. other information, call (866) 208–3676 Docket Numbers: ER16–98–001. (toll free). For TTY, call (202) 502–8659. Applicants: Windom Transmission, Dated: December 2, 2015. LLC. Description: Tariff Amendment: Nathaniel J. Davis, Sr., Amended Transmission and Deputy Secretary. Interconnection Agreement to be [FR Doc. 2015–30846 Filed 12–7–15; 8:45 am] effective 12/15/2015. BILLING CODE 6717–01–P Filed Date: 12/2/15. Accession Number: 20151202–5184. Comments Due: 5 p.m. ET 12/23/15. DEPARTMENT OF ENERGY Docket Numbers: ER16–450–000. Federal Energy Regulatory Applicants: RE Columbia Two LLC. Commission Description: Compliance filing: Compliance Filing—RE Columbia Two [Docket No. CP15–505–000] Removal of Affiliate Waiver to be Natural Gas Pipeline Company of effective 11/1/2015. America, LLC; Notice of Schedule for Filed Date: 12/2/15. Environmental Review of the Chicago Accession Number: 20151202–5142. Market Expansion Project Comments Due: 5 p.m. ET 12/23/15. Docket Numbers: ER16–451–000. On June 1, 2015, Natural Gas Pipeline Applicants: KCP&L Greater Missouri Company of America, LLC (Natural) Operations Company. filed an application in Docket No. Description: KCP&L Greater Missouri CP15–505–000 requesting a Certificate Operations Company Notice of of Public Convenience and Necessity Cancellation of Interconnection pursuant to Section 7(c) of the Natural Agreement. Gas Act to construct and operate certain Filed Date: 12/2/15. natural gas pipeline facilities. The Accession Number: 20151202–5174. proposed project is known as the Comments Due: 5 p.m. ET 12/23/15. Chicago Market Expansion Project Docket Numbers: ER16–452–000. (Project), and would provide about Applicants: RE Tranquillity LLC. 238,000 dekatherms of incremental Description: Baseline eTariff Filing: northbound firm transportation capacity Application and Initial BaselineTariff to the city of Chicago, Illinois and Filing to be effective 12/3/2015. neighboring areas. Filed Date: 12/2/15. On June 12, 2015, the Federal Energy Accession Number: 20151202–5200. Regulatory Commission (Commission or PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 E:\FR\FM\08DEN1.SGM 08DEN1

Agencies

[Federal Register Volume 80, Number 235 (Tuesday, December 8, 2015)]
[Notices]
[Pages 76279-76280]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-30861]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting

AGENCY: Assistant Secretary of Defense (Health Affairs), DoD.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense is publishing this notice to 
announce a Federal Advisory Committee meeting of the Uniform Formulary 
Beneficiary Advisory Panel (hereafter referred to as the Panel).

DATES: Thursday, January 7, 2016, from 9:00 a.m. to 1:00 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: CAPT Edward Norton, DFO, Uniform 
Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 
5101, Falls Church, VA 22042-5101. Telephone: (703) 681-2890. Fax: 
(703) 681-1940. Email Address: dha.ncr.health-it.mbx.baprequests@mail.mil.

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act of 1972 (Title 5, 
United States Code (U.S.C.), Appendix, as amended) and the Government 
in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended).
    Purpose of Meeting: The Panel will review and comment on 
recommendations made to the Director of Defense Health Agency, by the 
Pharmacy and Therapeutics Committee, regarding the Uniform Formulary.

Meeting Agenda

1. Sign-In
2. Welcome and Opening Remarks
3. Public Citizen Comments
4. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item)
    a. Attention Deficit Hyperactivity Disorder (ADHD)--Stimulants
    b. Antirheumatic Drugs--Methotrexate Injectable
    c. Gastrointestinal -2 Agents--Miscellaneous
    d. Acne--Isotretinoins
5. Designated Newly Approved Drugs in Already-Reviewed Classes
6. Designated Newly FDA Approved Drugs
7. Pertinent Utilization Management Issues
8. Panel Discussions and Vote

    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 
41 Code of Federal Regulations (CFR) 102-3.140 through 102-3.165, and 
the availability of space, this meeting is open to the public. Seating 
is limited and will be provided only to the first 220 people signing-
in. All persons must sign-in legibly.
    Administrative Work Meeting: Prior to the public meeting, the Panel 
will conduct an Administrative Work Meeting from 7:45 a.m. to 9:00 a.m. 
to discuss administrative matters of the

[[Page 76280]]

Panel. The Administrative Work Meeting will be held at the Naval 
Heritage Center, 701 Pennsylvania Avenue NW., Washington, DC 20004. 
Pursuant to 41 CFR 102-3.160, the Administrative Work Meeting will be 
closed to the public.
    Written Statements: Pursuant to 41 CFR 102-3.140, the public or 
interested organizations may submit written statements to the 
membership of the Panel at any time or in response to the stated agenda 
of a planned meeting. Written statements should be submitted to the 
Panel's Designated Federal Officer (DFO). The DFO's contact information 
can be obtained from the General Services Administration's Federal 
Advisory Committee Act Database at https://facadatabase.gov/. Written 
statements that do not pertain to the scheduled meeting of the Panel 
may be submitted at any time. However, if individual comments pertain 
to a specific topic being discussed at a planned meeting, then these 
statements must be submitted no later than 5 business days prior to the 
meeting in question. The DFO will review all submitted written 
statements and provide copies to all the committee members.
    Public Comments: In addition to written statements, the Panel will 
set aside 1 hour for individuals or interested groups to address the 
Panel. To ensure consideration of their comments, individuals and 
interested groups should submit written statements as outlined in this 
notice; but if they still want to address the Panel, then they will be 
afforded the opportunity to register to address the Panel. The Panel's 
DFO will have a ``Sign-Up Roster'' available at the Panel meeting for 
registration on a first-come, first-serve basis. Those wishing to 
address the Panel will be given no more than 5 minutes to present their 
comments, and at the end of the 1 hour time period, no further public 
comments will be accepted. Anyone who signs-up to address the Panel, 
but is unable to do so due to the time limitation, may submit their 
comments in writing; however, they must understand that their written 
comments may not be reviewed prior to the Panel's deliberation.
    To ensure timeliness of comments for the official record, the Panel 
encourages that individuals and interested groups consider submitting 
written statements instead of addressing the Panel.

    Dated: December 3, 2015.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2015-30861 Filed 12-7-15; 8:45 am]
 BILLING CODE 5001-06-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.